304 related articles for article (PubMed ID: 27271601)
1. Mechanism of Action and Applications of Interleukin 24 in Immunotherapy.
Persaud L; De Jesus D; Brannigan O; Richiez-Paredes M; Huaman J; Alvarado G; Riker L; Mendez G; Dejoie J; Sauane M
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271601
[TBL] [Abstract][Full Text] [Related]
2. Biological and pathological activities of interleukin-22.
Perusina Lanfranca M; Lin Y; Fang J; Zou W; Frankel T
J Mol Med (Berl); 2016 May; 94(5):523-34. PubMed ID: 26923718
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-21 signaling: functions in cancer and autoimmunity.
Davis ID; Skak K; Smyth MJ; Kristjansen PE; Miller DM; Sivakumar PV
Clin Cancer Res; 2007 Dec; 13(23):6926-32. PubMed ID: 18056166
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 32, inflammation and cancer.
Hong JT; Son DJ; Lee CK; Yoon DY; Lee DH; Park MH
Pharmacol Ther; 2017 Jun; 174():127-137. PubMed ID: 28223235
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and tumor cell apoptosis inducing activity of mda-7/IL-24.
Gopalkrishnan RV; Sauane M; Fisher PB
Int Immunopharmacol; 2004 May; 4(5):635-47. PubMed ID: 15120649
[TBL] [Abstract][Full Text] [Related]
6. IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection.
Zeng S; Wu J; Liu J; Qi F; Liu B
Scand J Immunol; 2015 Jun; 81(6):494-501. PubMed ID: 25721734
[TBL] [Abstract][Full Text] [Related]
7. Ceramide plays a prominent role in MDA-7/IL-24-induced cancer-specific apoptosis.
Sauane M; Su ZZ; Dash R; Liu X; Norris JS; Sarkar D; Lee SG; Allegood JC; Dent P; Spiegel S; Fisher PB
J Cell Physiol; 2010 Mar; 222(3):546-55. PubMed ID: 19937735
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22.
de Moura PR; Watanabe L; Bleicher L; Colau D; Dumoutier L; Lemaire MM; Renauld JC; Polikarpov I
FEBS Lett; 2009 Apr; 583(7):1072-7. PubMed ID: 19285080
[TBL] [Abstract][Full Text] [Related]
9. Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
Chada S; Mhashilkar AM; Ramesh R; Mumm JB; Sutton RB; Bocangel D; Zheng M; Grimm EA; Ekmekcioglu S
Mol Ther; 2004 Dec; 10(6):1085-95. PubMed ID: 15564140
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-24 and its receptors.
Wang M; Liang P
Immunology; 2005 Feb; 114(2):166-70. PubMed ID: 15667561
[TBL] [Abstract][Full Text] [Related]
11. mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer.
Chada S; Bocangel D; Ramesh R; Grimm EA; Mumm JB; Mhashilkar AM; Zheng M
Mol Ther; 2005 May; 11(5):724-33. PubMed ID: 15851011
[TBL] [Abstract][Full Text] [Related]
12. The IL-12 cytokine family in cardiovascular diseases.
van der Heijden T; Bot I; Kuiper J
Cytokine; 2019 Oct; 122():154188. PubMed ID: 29074035
[TBL] [Abstract][Full Text] [Related]
13. IL-27 in tumor immunity and immunotherapy.
Murugaiyan G; Saha B
Trends Mol Med; 2013 Feb; 19(2):108-16. PubMed ID: 23306374
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-21: a new modulator of immunity, infection, and cancer.
Brandt K; Singh PB; Bulfone-Paus S; Rückert R
Cytokine Growth Factor Rev; 2007; 18(3-4):223-32. PubMed ID: 17509926
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 24: mechanisms and therapeutic potential of an anti-cancer gene.
Whitaker EL; Filippov VA; Duerksen-Hughes PJ
Cytokine Growth Factor Rev; 2012 Dec; 23(6):323-31. PubMed ID: 22981288
[TBL] [Abstract][Full Text] [Related]
16. IL22/IL-22R pathway induces cell survival in human glioblastoma cells.
Akil H; Abbaci A; Lalloué F; Bessette B; Costes LM; Domballe L; Charreau S; Guilloteau K; Karayan-Tapon L; Bernard FX; Morel F; Jauberteau MO; Lecron JC
PLoS One; 2015; 10(3):e0119872. PubMed ID: 25793261
[TBL] [Abstract][Full Text] [Related]
17. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
[TBL] [Abstract][Full Text] [Related]
18. IL-21 Signaling in the Tumor Microenvironment.
Chabab G; Bonnefoy N; Lafont V
Adv Exp Med Biol; 2020; 1240():73-82. PubMed ID: 32060889
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 21 - its potential role in the therapy of B-cell lymphomas.
Bhatt S; Sarosiek KA; Lossos IS
Leuk Lymphoma; 2017 Jan; 58(1):17-29. PubMed ID: 27405876
[TBL] [Abstract][Full Text] [Related]
20. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
